{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:49:37Z","timestamp":1776779377307,"version":"3.51.2"},"posted":{"date-parts":[[2025,5,13]]},"group-title":"In Review","reference-count":56,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,4,29]]},"abstract":"<title>Abstract<\/title>\n        <p>Background\n Translational models using nonhuman primates provide valuable insights into the pathological changes associated with human brain aging. This study investigates the vervet monkey (<italic>Chlorocebus aethiops sabaeus<\/italic>) as a model for age-related Alzheimer\u2019s disease (AD)-like amyloid clearance impairment. The cerebrospinal fluid (CSF) plays a crucial role as a transport medium for waste clearance from the brain\u2019s interstitial space to lymphatic vessels.\nMethods\n To test the hypothesis that diminished CSF perfusion in the central nervous system contributes to AD pathophysiology, we quantified CSF flow dynamics (i.e. stroke volume, amplitude and peak flow) in the spinal canal via phase-contrast MRI and examined its association with age and AD fluid biomarkers in 16 female vervet monkeys aged from 10 to 27 years.\nResults\n Strong negative correlations were observed between CSF flow metrics across the cardiac cycle and age (\u03c1 = -0.68 to -0.83), and positive correlations were found between CSF flow metrics and CSF A\u03b242\/40 ratio (\u03c1\u2009=\u20090.67 to 0.84), while plasma biomarkers showed no correlation with CSF flow metrics. Age-adjusted analyses demonstrated moderate correlations between CSF flow and CSF A\u03b242\/40 ratio (\u03c1\u2009=\u20090.45 to 0.75).\nConclusion\n These findings suggest that diminished CSF flow dynamics in the central nervous system could serve as a valuable imaging marker for impaired amyloid clearance, reflecting early-stage AD-like pathology.<\/p>","DOI":"10.21203\/rs.3.rs-6551242\/v1","type":"posted-content","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T12:12:51Z","timestamp":1747138371000},"source":"Crossref","is-referenced-by-count":1,"title":["Effects of Diminished Cerebrospinal Fluid Flow in the Spinal Canal on Amyloid Pathophysiology in Vervet Monkeys"],"prefix":"10.21203","author":[{"given":"Jeongchul","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Radiology, Wake Forest School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan E.","family":"Lipford","sequence":"additional","affiliation":[{"name":"Department of Radiology, Wake Forest School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Barcus","sequence":"additional","affiliation":[{"name":"Department of Radiology, Wake Forest School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett M.","family":"Frye","sequence":"additional","affiliation":[{"name":"Department of Biology, Emory and Henry University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Radiology, Wake Forest School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Lyu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Wake Forest School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy P.","family":"Hudson","sequence":"additional","affiliation":[{"name":"Department of Radiology, Wake Forest School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel N.","family":"Lockhart","sequence":"additional","affiliation":[{"name":"Division of Geriatric Medicine, Department of Internal Medicine, Wake Forest School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney L.","family":"Sutphen","sequence":"additional","affiliation":[{"name":"Wake Forest Alzheimer's Disease Research Center, Wake Forest School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Register","sequence":"additional","affiliation":[{"name":"Wake Forest Alzheimer's Disease Research Center, Wake Forest School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M.","family":"Mielke","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Prevention, Wake Forest School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Craft","sequence":"additional","affiliation":[{"name":"Division of Geriatric Medicine, Department of Internal Medicine, Wake Forest School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A.","family":"Shively","sequence":"additional","affiliation":[{"name":"Department of Pathology, Section on Comparative Medicine, Wake Forest School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher T.","family":"Whitlow","sequence":"additional","affiliation":[{"name":"Department of Radiology, Wake Forest School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"2024 Alzheimer's disease facts and figures. Alzheimers Dement 2024, 20(5):3708\u20133821.","DOI":"10.1002\/alz.13809"},{"issue":"5580","key":"ref2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy J","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353\u20136.","journal-title":"Science"},{"issue":"6012","key":"ref3","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega KG","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ. Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science. 2010;330(6012):1774.","journal-title":"Science"},{"issue":"147","key":"ref4","doi-asserted-by":"crossref","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta","volume":"4","author":"Iliff JJ","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE, Deane R, Goldman SA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med. 2012;4(147):147ra111.","journal-title":"Sci Transl Med"},{"issue":"14","key":"ref5","doi-asserted-by":"crossref","DOI":"10.1172\/JCI171838","article-title":"Connections between ApoE, sleep, and Abeta and tau pathologies in Alzheimer's disease","volume":"133","author":"Sadleir KR","year":"2023","unstructured":"Sadleir KR, Vassar R. Connections between ApoE, sleep, and Abeta and tau pathologies in Alzheimer's disease. J Clin Invest 2023, 133(14).","journal-title":"J Clin Invest"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The Amyloid-beta Pathway in Alzheimer's Disease","volume":"26","author":"Hampel H","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, et al. The Amyloid-beta Pathway in Alzheimer's Disease. Mol Psychiatry. 2021;26(10):5481\u2013503.","journal-title":"Mol Psychiatry"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer's amyloid-ss(1\u201340) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier","volume":"106","author":"Shibata M","year":"2000","unstructured":"Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, et al. Clearance of Alzheimer's amyloid-ss(1\u201340) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest. 2000;106(12):1489\u201399.","journal-title":"J Clin Invest"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway JM","year":"2015","unstructured":"Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV, et al. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol. 2015;11(8):457\u201370.","journal-title":"Nat Rev Neurol"},{"issue":"7560","key":"ref9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau A","year":"2015","unstructured":"Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, Derecki NC, Castle D, Mandell JW, Lee KS, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523(7560):337\u201341.","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"932469","DOI":"10.3389\/fbioe.2022.932469","article-title":"CSF circulation and dispersion yield rapid clearance from intracranial compartments","volume":"10","author":"Hornkjol M","year":"2022","unstructured":"Hornkjol M, Valnes LM, Ringstad G, Rognes ME, Eide PK, Mardal KA, Vinje V. CSF circulation and dispersion yield rapid clearance from intracranial compartments. Front Bioeng Biotechnol. 2022;10:932469.","journal-title":"Front Bioeng Biotechnol"},{"issue":"7717","key":"ref11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/d41586-018-05763-0","article-title":"A lymphatic waste-disposal system implicated in Alzheimer's disease","volume":"560","author":"Sweeney MD","year":"2018","unstructured":"Sweeney MD, Zlokovic BV. A lymphatic waste-disposal system implicated in Alzheimer's disease. Nature. 2018;560(7717):172\u20134.","journal-title":"Nature"},{"issue":"7996","key":"ref12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s41586-023-06899-4","article-title":"Nasopharyngeal lymphatic plexus is a hub for cerebrospinal fluid drainage","volume":"625","author":"Yoon JH","year":"2024","unstructured":"Yoon JH, Jin H, Kim HJ, Hong SP, Yang MJ, Ahn JH, Kim YC, Seo J, Lee Y, McDonald DM, et al. Nasopharyngeal lymphatic plexus is a hub for cerebrospinal fluid drainage. Nature. 2024;625(7996):768\u201377.","journal-title":"Nature"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1212\/01.wnl.0000167542.89697.0f","article-title":"Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months","volume":"65","author":"Schott JM","year":"2005","unstructured":"Schott JM, Price SL, Frost C, Whitwell JL, Rossor MN, Fox NC. Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months. Neurology. 2005;65(1):119\u201324.","journal-title":"Neurology"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JAD-2012-111964","article-title":"A possible role for CSF turnover and choroid plexus in the pathogenesis of late onset Alzheimer's disease","volume":"30","author":"Serot JM","year":"2012","unstructured":"Serot JM, Zmudka J, Jouanny P. A possible role for CSF turnover and choroid plexus in the pathogenesis of late onset Alzheimer's disease. J Alzheimers Dis. 2012;30(1):17\u201326.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.bbadis.2015.10.014","article-title":"Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease","volume":"1862","author":"Simon MJ","year":"2016","unstructured":"Simon MJ, Iliff JJ. Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease. Biochim Biophys Acta. 2016;1862(3):442\u201351.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","article-title":"Alzheimer's disease: experimental models and reality","volume":"133","author":"Drummond E","year":"2017","unstructured":"Drummond E, Wisniewski T. Alzheimer's disease: experimental models and reality. Acta Neuropathol. 2017;133(2):155\u201375.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jalz.2018.06.3057","article-title":"A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis","volume":"15","author":"Latimer CS","year":"2019","unstructured":"Latimer CS, Shively CA, Keene CD, Jorgensen MJ, Andrews RN, Register TC, Montine TJ, Wilson AM, Neth BJ, Mintz A, et al. A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis. Alzheimers Dement. 2019;15(1):93\u2013105.","journal-title":"Alzheimers Dement"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2741\/1370","article-title":"Cognitive function and its neural mechanisms in nonhuman primate models of aging, Alzheimer disease, and menopause","volume":"9","author":"Voytko ML","year":"2004","unstructured":"Voytko ML, Tinkler GP. Cognitive function and its neural mechanisms in nonhuman primate models of aging, Alzheimer disease, and menopause. Front bioscience: J virtual Libr. 2004;9:1899\u2013914.","journal-title":"Front bioscience: J virtual Libr"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1002\/ajp.22281","article-title":"Why primate models matter","author":"Phillips KA","year":"2014","unstructured":"Phillips KA, Bales KL, Capitanio JP, Conley A, Czoty PW, t Hart BA, Hopkins WD, Hu SL, Miller LA, Nader MA et al. Why primate models matter. Am J Primatol 2014.","journal-title":"Am J Primatol"},{"issue":"6","key":"ref20","first-page":"1423","article-title":"Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease","volume":"138","author":"Podlisny MB","year":"1991","unstructured":"Podlisny MB, Tolan DR, Selkoe DJ. Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease. Am J Pathol. 1991;138(6):1423\u201335.","journal-title":"Am J Pathol"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11357-016-9924-z","article-title":"Microbial translocation and skeletal muscle in young and old vervet monkeys","volume":"38","author":"Kavanagh K","year":"2016","unstructured":"Kavanagh K, Brown RN, Davis AT, Uberseder B, Floyd E, Pfisterer B, Shively CA. Microbial translocation and skeletal muscle in young and old vervet monkeys. Age (Dordr). 2016;38(3):58.","journal-title":"Age (Dordr)"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1177\/0300985810370011","article-title":"Clinicopathologic characterization of naturally occurring diabetes mellitus in vervet monkeys","volume":"47","author":"Cann JA","year":"2010","unstructured":"Cann JA, Kavanagh K, Jorgensen MJ, Mohanan S, Howard TD, Gray SB, Hawkins GA, Fairbanks LA, Wagner JD. Clinicopathologic characterization of naturally occurring diabetes mellitus in vervet monkeys. Vet Pathol. 2010;47(4):713\u20138.","journal-title":"Vet Pathol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3389\/fnins.2019.00843","article-title":"Type-2-Diabetes Alters CSF but Not Plasma Metabolomic and AD Risk Profiles in Vervet Monkeys","volume":"13","author":"Kavanagh K","year":"2019","unstructured":"Kavanagh K, Day SM, Pait MC, Mortiz WR, Newgard CB, Ilkayeva O, McClain DA, Macauley SL. Type-2-Diabetes Alters CSF but Not Plasma Metabolomic and AD Risk Profiles in Vervet Monkeys. Front Neurosci. 2019;13:843.","journal-title":"Front Neurosci"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jse.2012.11.004","article-title":"Age-related degenerative functional, radiographic, and histological changes of the shoulder in nonhuman primates","volume":"22","author":"Plate JF","year":"2013","unstructured":"Plate JF, Bates CM, Mannava S, Smith TL, Jorgensen MJ, Register TC, Stehle JR, High KP, Shively CA, Kaplan JR, et al. Age-related degenerative functional, radiographic, and histological changes of the shoulder in nonhuman primates. J Shoulder Elb Surg. 2013;22(8):1019\u201329.","journal-title":"J Shoulder Elb Surg"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/ilar\/ilt049","article-title":"Systems Biology of the Vervet Monkey","volume":"54","author":"Jasinska AJ","year":"2013","unstructured":"Jasinska AJ, Schmitt CA, Service SK, Cantor RM, Dewar K, Jentsch JD, Kaplan JR, Turner TR, Warren WC, Weinstock GM, et al. Systems Biology of the Vervet Monkey. ILAR J. 2013;54(2):122\u201343.","journal-title":"ILAR J"},{"key":"ref26","author":"Magden ERMK","year":"2015","unstructured":"Magden ERMK, Simmons JH, Abee CR. Nonhuman Primates. In: Laboratory Animal Medicine. 3rd Edition. edn. Edited by Fox JG AL, Otto GM, Pritchett-Corning KR, Whary MT. San Diego, CA: Academic Press; 2015: 771\u2013930."},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s11357-021-00338-w","article-title":"Temporal emergence of age-associated changes in cognitive and physical function in vervets (Chlorocebus aethiops sabaeus)","volume":"43","author":"Frye BM","year":"2021","unstructured":"Frye BM, Valure PM, Craft S, Baxter MG, Scott C, Wise-Walden S, Bissinger DW, Register HM, Copeland C, Jorgensen MJ, et al. Temporal emergence of age-associated changes in cognitive and physical function in vervets (Chlorocebus aethiops sabaeus). Geroscience. 2021;43(3):1303\u201315.","journal-title":"Geroscience"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"e12284","DOI":"10.1002\/trc2.12284","article-title":"Early Alzheimer's disease-like reductions in gray matter and cognitive function with aging in nonhuman primates","volume":"8","author":"Frye BM","year":"2022","unstructured":"Frye BM, Craft S, Register TC, Kim J, Whitlow CT, Barcus RA, Lockhart SN, Sai KKS, Shively CA. Early Alzheimer's disease-like reductions in gray matter and cognitive function with aging in nonhuman primates. Alzheimers Dement (N Y). 2022;8(1):e12284.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"e23260","DOI":"10.1002\/ajp.23260","article-title":"Aging-related Alzheimer's disease-like neuropathology and functional decline in captive vervet monkeys (Chlorocebus aethiops sabaeus)","volume":"83","author":"Frye BM","year":"2021","unstructured":"Frye BM, Craft S, Latimer CS, Keene CD, Montine TJ, Register TC, Orr ME, Kavanagh K, Macauley SL, Shively CA. Aging-related Alzheimer's disease-like neuropathology and functional decline in captive vervet monkeys (Chlorocebus aethiops sabaeus). Am J Primatol. 2021;83(11):e23260.","journal-title":"Am J Primatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neurobiolaging.2017.12.011","article-title":"Aging African green monkeys manifest transcriptional, pathological, and cognitive hallmarks of human Alzheimer's disease","volume":"64","author":"Cramer PE","year":"2018","unstructured":"Cramer PE, Gentzel RC, Tanis KQ, Vardigan J, Wang Y, Connolly B, Manfre P, Lodge K, Renger JJ, Zerbinatti C, et al. Aging African green monkeys manifest transcriptional, pathological, and cognitive hallmarks of human Alzheimer's disease. Neurobiol Aging. 2018;64:92\u2013106.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"ref31","first-page":"1123","article-title":"Aging and physical mobility in group-housed Old World monkeys","volume":"34","author":"Shively CA","year":"2012","unstructured":"Shively CA. Aging and physical mobility in group-housed Old World monkeys. Acta dermato-venereologica. 2012;34(5):1123\u201331.","journal-title":"Acta dermato-venereologica"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.neurobiolaging.2013.03.023","article-title":"Development of amyloid burden in African Green monkeys","volume":"34","author":"Kalinin S","year":"2013","unstructured":"Kalinin S, Willard SL, Shively CA, Kaplan JR, Register TC, Jorgensen MJ, Polak PE, Rubinstein I, Feinstein DL. Development of amyloid burden in African Green monkeys. Neurobiol Aging. 2013;34(10):2361\u20139.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0002-9440(10)63296-8","article-title":"Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet","volume":"165","author":"Lemere CA","year":"2004","unstructured":"Lemere CA, Beierschmitt A, Iglesias M, Spooner ET, Bloom JK, Leverone JF, Zheng JB, Seabrook TJ, Louard D, Li D, et al. Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet. Am J Pathol. 2004;165(1):283\u201397.","journal-title":"Am J Pathol"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1148\/radiology.178.2.1987610","article-title":"Normal flow patterns of intracranial and spinal cerebrospinal fluid defined with phase-contrast cine MR imaging","volume":"178","author":"Enzmann DR","year":"1991","unstructured":"Enzmann DR, Pelc NJ. Normal flow patterns of intracranial and spinal cerebrospinal fluid defined with phase-contrast cine MR imaging. Radiology. 1991;178(2):467\u201374.","journal-title":"Radiology"},{"issue":"4","key":"ref35","first-page":"229","article-title":"Phase contrast cine magnetic resonance imaging","volume":"7","author":"Pelc NJ","year":"1991","unstructured":"Pelc NJ, Herfkens RJ, Shimakawa A, Enzmann DR. Phase contrast cine magnetic resonance imaging. Magn Reson Q. 1991;7(4):229\u201354.","journal-title":"Magn Reson Q"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.7198991","article-title":"Laplacian-based Phase Unwrapping in Python (v1.0)","author":"Blake E","year":"2022","unstructured":"Blake E, Dewey. (2022). Laplacian-based Phase Unwrapping in Python (v1.0). Zenodo. https:\/\/doi.org\/10.5281\/zenodo.7198991"},{"issue":"10","key":"ref37","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/acn3.635","article-title":"Aging and APOE-epsilon4 are determinative factors of plasma Abeta42 levels","volume":"5","author":"Nakamura T","year":"2018","unstructured":"Nakamura T, Kawarabayashi T, Seino Y, Hirohata M, Nakahata N, Narita S, Itoh K, Nakaji S, Shoji M. Aging and APOE-epsilon4 are determinative factors of plasma Abeta42 levels. Ann Clin Transl Neurol. 2018;5(10):1184\u201391.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"e12374","DOI":"10.1002\/dad2.12374","article-title":"Longitudinal CSF Alzheimer's disease biomarker changes from middle age to late adulthood","volume":"14","author":"Pettigrew C","year":"2022","unstructured":"Pettigrew C, Soldan A, Wang J, Wang MC, Greenberg B, Albert M, Moghekar A, Team BR. Longitudinal CSF Alzheimer's disease biomarker changes from middle age to late adulthood. Alzheimers Dement (Amst). 2022;14(1):e12374.","journal-title":"Alzheimers Dement (Amst)"},{"key":"ref39","author":"Bridel C","year":"2019","unstructured":"Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, and the, NFLG, Alvarez-Cermeno JC, Andreasson U, Axelsson M, Backstrom DC et al. Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis. JAMA Neurol 2019, 76(9):1035\u20131048."},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s41467-020-14612-6","article-title":"Serum neurofilament light levels in normal aging and their association with morphologic brain changes","volume":"11","author":"Khalil M","year":"2020","unstructured":"Khalil M, Pirpamer L, Hofer E, Voortman MM, Barro C, Leppert D, Benkert P, Ropele S, Enzinger C, Fazekas F, et al. Serum neurofilament light levels in normal aging and their association with morphologic brain changes. Nat Commun. 2020;11(1):812.","journal-title":"Nat Commun"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00401-018-1862-7","article-title":"Convective influx\/glymphatic system: tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways","volume":"136","author":"Albargothy NJ","year":"2018","unstructured":"Albargothy NJ, Johnston DA, MacGregor-Sharp M, Weller RO, Verma A, Hawkes CA, Carare RO. Convective influx\/glymphatic system: tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways. Acta Neuropathol. 2018;136(1):139\u201352.","journal-title":"Acta Neuropathol"},{"issue":"7717","key":"ref42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41586-018-0368-8","article-title":"Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease","volume":"560","author":"Mesquita S","year":"2018","unstructured":"Da Mesquita S, Louveau A, Vaccari A, Smirnov I, Cornelison RC, Kingsmore KM, Contarino C, Onengut-Gumuscu S, Farber E, Raper D, et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease. Nature. 2018;560(7717):185\u201391.","journal-title":"Nature"},{"issue":"7767","key":"ref43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41586-019-1419-5","article-title":"Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid","volume":"572","author":"Ahn JH","year":"2019","unstructured":"Ahn JH, Cho H, Kim JH, Kim SH, Ham JS, Park I, Suh SH, Hong SP, Song JH, Hong YK, et al. Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid. Nature. 2019;572(7767):62\u20136.","journal-title":"Nature"},{"issue":"Suppl 1","key":"ref44","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2967\/jnumed.121.263195","article-title":"The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review","volume":"63","author":"Chapleau M","year":"2022","unstructured":"Chapleau M, Iaccarino L, Soleimani-Meigooni D, Rabinovici GD. The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review. J Nucl Med. 2022;63(Suppl 1):S13\u20139.","journal-title":"J Nucl Med"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/s41598-022-06361-x","article-title":"Deep breathing couples CSF and venous flow dynamics","volume":"12","author":"Kollmeier JM","year":"2022","unstructured":"Kollmeier JM, Gurbuz-Reiss L, Sahoo P, Badura S, Ellebracht B, Keck M, Gartner J, Ludwig HC, Frahm J, Dreha-Kulaczewski S. Deep breathing couples CSF and venous flow dynamics. Sci Rep. 2022;12(1):2568.","journal-title":"Sci Rep"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"10894","DOI":"10.1038\/s41598-022-15034-8","article-title":"Immediate impact of yogic breathing on pulsatile cerebrospinal fluid dynamics","volume":"12","author":"Yildiz S","year":"2022","unstructured":"Yildiz S, Grinstead J, Hildebrand A, Oshinski J, Rooney WD, Lim MM, Oken B. Immediate impact of yogic breathing on pulsatile cerebrospinal fluid dynamics. Sci Rep. 2022;12(1):10894.","journal-title":"Sci Rep"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease","volume":"9","author":"Budd Haeberlein S","year":"2022","unstructured":"Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, Dent G, Hansson O, Harrison K, von Hehn C, et al. Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease. J Prev Alzheimers Dis. 2022;9(2):197\u2013210.","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer's Disease","volume":"388","author":"Dyck CH","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, et al. Lecanemab in Early Alzheimer's Disease. N Engl J Med. 2023;388(1):9\u201321.","journal-title":"N Engl J Med"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13311-022-01308-6","article-title":"Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease","volume":"20","author":"Soderberg L","year":"2023","unstructured":"Soderberg L, Johannesson M, Nygren P, Laudon H, Eriksson F, Osswald G, Moller C, Lannfelt L. Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease. Neurotherapeutics. 2023;20(1):195\u2013206.","journal-title":"Neurotherapeutics"},{"issue":"8","key":"ref50","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.4049\/jimmunol.167.8.4644","article-title":"Meningeal and perivascular macrophages of the central nervous system play a protective role during bacterial meningitis","volume":"167","author":"Polfliet MM","year":"2001","unstructured":"Polfliet MM, Zwijnenburg PJ, van Furth AM, van der Poll T, Dopp EA, Renardel de Lavalette C, van Kesteren-Hendrikx EM, van Rooijen N, Dijkstra CD, van den Berg TK. Meningeal and perivascular macrophages of the central nervous system play a protective role during bacterial meningitis. J Immunol. 2001;167(8):4644\u201350.","journal-title":"J Immunol"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/brain\/awad304","article-title":"Brain perivascular macrophages: current understanding and future prospects","volume":"147","author":"Wen W","year":"2024","unstructured":"Wen W, Cheng J, Tang Y. Brain perivascular macrophages: current understanding and future prospects. Brain. 2024;147(1):39\u201355.","journal-title":"Brain"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/CLEP.S37929","article-title":"Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences","volume":"6","author":"Mielke MM","year":"2014","unstructured":"Mielke MM, Vemuri P, Rocca WA. Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences. Clin Epidemiol. 2014;6:37\u201348.","journal-title":"Clin Epidemiol"},{"key":"ref53","unstructured":"2020 Alzheimer's disease facts and figures. Alzheimers Dement 2020."},{"issue":"6","key":"ref54","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.molmed.2017.04.001","article-title":"The Exceptional Vulnerability of Humans to Alzheimer's Disease","volume":"23","author":"Walker LC","year":"2017","unstructured":"Walker LC, Jucker M. The Exceptional Vulnerability of Humans to Alzheimer's Disease. Trends Mol Med. 2017;23(6):534\u201345.","journal-title":"Trends Mol Med"},{"issue":"6","key":"ref55","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00006842-199611000-00008","article-title":"Psychosocial factors, sex differences, and atherosclerosis: lessons from animal models","volume":"58","author":"Kaplan JR","year":"1996","unstructured":"Kaplan JR, Adams MR, Clarkson TB, Manuck SB, Shively CA, Williams JK. Psychosocial factors, sex differences, and atherosclerosis: lessons from animal models. Psychosom Med. 1996;58(6):598\u2013611.","journal-title":"Psychosom Med"},{"issue":"8","key":"ref56","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2174\/138161212799315885","article-title":"Nonhuman primate models of Alzheimer-like cerebral proteopathy","volume":"18","author":"Heuer E","year":"2012","unstructured":"Heuer E, Rosen RF, Cintron A, Walker LC. Nonhuman primate models of Alzheimer-like cerebral proteopathy. Curr Pharm Des. 2012;18(8):1159\u201369.","journal-title":"Curr Pharm Des"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6551242\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6551242\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T14:54:36Z","timestamp":1748357676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6551242\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":56,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-6551242\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,5,13]]},"subtype":"preprint"}}